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Long-term alcohol exposure sensitizes hepatocytes
to tumor necrosis factor- (TNF) cytotoxicity. 4-
Hydroxynonenal (4-HNE) is one of the most abundant
and reactive lipid peroxides. Increased hepatic 4-HNE
contents present in both human alcoholics and alco-
hol-fed animals. In the present study, we investigated
the effects of intracellular 4-HNE accumulation on
TNF-induced hepatotoxicity and its potential implica-
tion in the pathogenesis of alcoholic liver disease.
Male C57BL/6 mice were fed an ethanol-containing or
a control diet for 5 weeks. Long-term alcohol expo-
sure increased hepatic 4-HNE and TNF levels. Cell
culture studies revealed that 4-HNE, at nontoxic con-
centrations, sensitized hepatocytes to TNF killing,
which was associated with suppressed NF-B transac-
tivity. Further investigation demonstrated that 4-HNE
prevented TNF-induced inhibitor of B phosphoryla-
tion without affecting upstream IB kinase activity. An
immunoprecipitation assay revealed that increased
4-HNE content was associated with increased formation
of 4-HNE–inhibitor of B adduction in both 4-HNE–
treated hepatocytes and in the livers of alcohol-fed
mice. Prevention of intracellular 4-HNE accumulation
by bezafibrate, a peroxisome proliferator-activated re-
ceptor- agonist, protected hepatocytes from TNF kill-
ing via NF-B activation. Supplementation of N-acetyl-
cysteine, a glutathione precursor, conferred a protective
effect on alcohol-induced liver injury in mice, was asso-
ciated with decreased hepatic 4-HNE formation, and im-
proved hepatic NF-B activity. In conclusion, increased
17024-HNE accumulation represents a potent and clinically
relevant sensitizer to TNF-induced hepatotoxicity. These
data support the notion that removal of intracellular
4-HNE can serve as a potential therapeutic option for
alcoholic liver disease. (Am J Pathol 2012, 181:1702–1710;
http://dx.doi.org/10.1016/j.ajpath.2012.08.004)
Oxidative stress plays a central and causal role in the
onset and progression of alcoholic liver disease (ALD).1,2
Long-term ethanol exposure increases production of re-
active oxygen species, lowers cellular antioxidant levels,
and leads to oxidative stress in the liver. Alcohol-induced
liver injury is associated with enhanced lipid peroxida-
tion, protein carbonyl formation, formation of lipid radi-
cals, and decreased hepatic antioxidant defenses.3–5
Replacement of polyunsaturated fat (required for lipid
peroxidation) with saturated fat or medium-chain triglyc-
erides lowers or prevents lipid peroxidation and alco-
hol-induced liver injury.6–8 In contrast, the addition of
iron, known to promote lipid peroxidation by Fenton’s
reaction, exacerbates liver injury.9,10 More important,
supplementation with antioxidants prevents alcohol-in-
duced liver injury.11,12
Overproduction of tumor necrosis factor- (TNF) con-
tributes to the pathogenesis of ALD. Patients with alco-
holic hepatitis have increased systemic TNF levels, which
correlate with disease severity and mortality.13–15 More-
over, a TNF promoter polymorphism has been linked with
susceptibility to alcoholic hepatitis.16 Compelling data
relating TNF to alcohol-induced liver injury in an experi-
mental setting from Thurman’s laboratory indicate that
anti-TNF antibody prevents liver injury in alcohol-fed
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not develop alcoholic liver injury.18
TNF induces both pro- and anti-apoptotic signaling.
TNF activates NF-B, inducing transcription of its target
genes primarily encoding survival proteins (eg, cellular
FLICE-like inhibitory protein and inhibitor of apoptosis
proteins) via formation of the complex I signalosome after
binding to TNF receptor-1. Depending on the cellular
signaling context, complex II can be formed from com-
plex I, which activates caspase-8 and pro-apoptotic
pathways. Activation of caspases and prolonged c-Jun
NH2 terminal kinase (JNK) signaling are, under normal
conditions, antagonized by various NF-B target genes.
Therefore, under normal physiological conditions, hepa-
tocytes are resistant to TNF-induced hepatotoxicity. How-
ever, several laboratories independently demonstrated
that long-term alcohol exposure sensitizes hepatocytes
to TNF-mediated hepatotoxicity. Subsequent investiga-
tions revealed that multiple mechanisms are implicated in
the sensitizing process, including mitochondrial permea-
bility transition pore opening,19 decreased mitochondrial
glutathione (GSH) levels,20 and increased intracellular
S-adenosylhomocysteine levels,21 all relevant to ALD.
Of lipid peroxides, 4-hydroxynonenal (4-HNE) is one of
the most abundant and reactive aldehydic products de-
rived from the oxidation of membrane n-6-polyunsatu-
rated fatty acids. Although increases in both 4-HNE for-
mation and TNF production are critically involved in the
disease development of ALD, it remains unclear if 4-HNE
may serve as a sensitizer to TNF-induced cell death in
hepatocytes. The present studies were conducted to test
this hypothesis. We report herein that exposure to 4-HNE,
at nontoxic or minimally toxic concentrations, sensitizes
hepatocytes to TNF-induced cell death via suppression
of NF-B activation.
Materials and Methods
Chemicals
All chemicals were obtained from Sigma-Aldrich (St.
Louis, MO), unless otherwise specified.
Hepatocytes and Culture Conditions
HepG2 and Hep3B cells, two human hepatoma cell lines,
were obtained from ATCC (Manassas, VA). Primary
mouse hepatocytes were obtained from Celsis In Vitro
Technologies (Baltimore, MD). Hepatocytes were cul-
tured in Dulbecco’s modified Eagle’s medium containing
10% (v/v) fetal bovine serum, 2 mmol/L glutamine, 5 U/mL
penicillin, and 50 g/mL streptomycin at 37°C in a hu-
midified O2/CO2 (19:1) atmosphere.
Animal Model and Experimental Protocol
Male C57BL/6 mice (Jackson Laboratory, Bar Harbor,
ME), weighing 25  0.5 g (mean  SD) were fed ad
libitum with an ethanol-containing Lieber-DeCarli diet
(ethanol-derived calories were increased from 30% to36% during the first 4 weeks, with a 2% increase each
week) or an isocaloric control liquid diet (Bioserv, French-
town, NJ) for 5 weeks. For N-acetylcysteine (NAC) sup-
plementation, NAC was added into the ethanol-contain-
ing diet at the dose of 0.16 mg/mL. Food intake and body
weight were recorded daily and weekly, respectively.
Mice were euthanized, and plasma and liver samples
were harvested at the end of the experiment.
Histological Analysis and in Situ Apoptosis
Detection
H&E staining of liver sections was performed as previ-
ously described.21 Apoptotic hepatocytes were detected
by TUNEL assay with a TUNEL assay kit (Intergen Com-
pany, Purchase, NY), as previously described.21
Cell Death Assays
Cell death was determined by measurement of lactate
dehydrogenase (LDH) release and MTT assay, as previ-
ously described.21 For Hoechst staining, 30 minutes be-
fore the end of the incubation with the indicated stimulus,
Hoechst was added to each well of 24-well plates at a
final concentration of 1 mol/L. At the completion of the
incubation, the cells were washed three times with ice-
cold PBS, and then the fluorescence was measured by
fluorescent microscope at an emission wavelength of 460
nm, using an excitation wavelength of 360 nm for the
dichlorofluorescein fluorophore.
ELISA for NF-B (p65) DNA-Binding Activity
NF-B (p65) DNA-binding activity in the nuclear fraction
of liver tissues or cultured cells was measured using
enzyme-linked immunosorbent assay (ELISA) kits (Cay-
man Chemical, Ann Arbor, MI), in accordance with the
manufacturer’s instructions.
Real-Time PCR
Total RNA isolation, reverse transcription, and real-time
PCR were performed as previously described.22 Briefly,
total RNA, from either frozen liver tissue or cultured cells,
was isolated with a phenol-chloroform extraction. For
each sample, 1 g of total RNA was reverse transcribed
using a high-capacity cDNA reverse transcription kit (Ap-
plied Biosystems, Foster City, CA). The cDNA was am-
plified in MicroAmp Optical 96-well reaction plates with
an SYBR Green PCR Master Mix (Applied Biosystems) on
a Prism 7000 sequence detection system (Applied Bio-
systems). Relative gene expression was calculated after
nomalization by a housekeeping gene (mouse or human
18S ribosomal RNA).
Western Blot Analysis
Western blot analysis was performed as previously de-
scribed,22 and the following antibodies were used: anti-
poly (ADP-ribose) polymerase (Novus Biologicals, Little-
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MN), anti-phospho-IB, anti-IB, anti-phosphorylated-
IB kinase (IKK), anti-IKK, anti-ubiquitin, anti-p65, anti-
phosphorylated-JNK, or anti-JNK (Cell Signaling Tech-
nology, Danvers, MA).
Immunoprecipitation
Cells were lysed in an immunoprecipitation buffer (150
mmol/L NaCl, 50 mmol/L Tris-HCl, and 1% Nonidet P-40,
pH 7.8) and a mammalian cell-specific protease inhibitor
cocktail. Total cellular extracts (200 g of protein) were
incubated with anti-IB antibody (1 g/mL) in immuno-
precipitation buffer overnight at 4°C on a rocker. The
antibody-protein mixture was agitated with Protein A/G
agarose (Santa Cruz Biotechnology, Santa Cruz, CA) for
1 hour at 4°C. The immunoprecipitates were washed four
times with immunoprecipitation buffer. The washed im-
munoprecipitates were incubated in 50 L of one times
electrophoresis loading buffer and heated at 100°C for 5
minutes. The beads were spun out and the supernatant
was resolved by SDS-PAGE, and the modification of IB
by 4-HNE or ubiquitination of IB was analyzed by using
Western blot analysis.
Statistical Analysis
All data were expressed as mean  SD. Statistical anal-
ysis was performed using a one-way analysis of variance,
and data were further analyzed by Newman-Keuls test for
statistical differences. Differences between treatments
were considered to be statistically significant at P 0.05.
Results
Liver Injury Induced by Long-Term Alcohol
Exposure Is Associated with Increased Hepatic
4-HNE and TNF Levels
Male C57BL/6 mice (aged 8 weeks), fed the Lieber-De-
Carli alcohol-containing liquid diet for 5 weeks, were
used as a model of ALD. Compared with pair-fed ani-
mals, alcohol-fed mice showed a significant increase in
hepatic triglyceride contents (Figure 1A) and hepatic ste-
atosis (Figure 1B). Alcohol exposure elevated plasma
alanine aminotransferase activity compared with pair-fed
animals (Figure 1C). TUNEL assays showed that alcohol
feeding was associated with increased hepatocyte apop-
tosis (Figure 1D). Moreover, hepatic TNF levels were
significantly increased after ethanol feeding (Figure 1E),
whereas circulating TNF levels were not affected by long-
term alcohol exposure (data not shown). To determine
the effect of long-term alcohol consumption on hepatic
4-HNE contents, Western blot analysis was conducted to
detect protein modification by 4-HNE using a polyclonal
anti–4-HNE antibody specifically binding to 4-HNE–mod-
ified proteins. As shown in Figure 1F, 5-week alcohol
feeding significantly increased hepatic 4-HNE contents
when compared with pair-fed animals.4-HNE Sensitizes Hepatocytes to TNF-Induced
Cytotoxicity
The association of liver injury and elevation in hepatic
4-HNE and TNF levels in alcohol-fed mice made us de-
termine whether 4-HNE may act as a sensitizer to TNF-
induced cell death in cultured hepatocytes. We first pre-
treated HepG2 cells with 4-HNE (0 to 60 mol/L) for 2
hours before TNF (0 to 40 ng/mL) stimulation. Cell death
was measured 16 hours later by MTT assay. As shown in
Figure 2A, 4-HNE sensitized HepG2 cells to TNF killing.
The conclusion was further confirmed by using Western
blot analysis for the cleaved form of poly (ADP-ribose)
polymerase-1 and fluorescence microscopic examina-
tion of Hoechst 33342 staining (Figure 2, B and C). To
determine its generality, cell death studies were repeated
in both Hep3B cells and primary mouse hepatocytes. As
shown in Figure 1D, the comparable results were ob-
served.
4-HNE Suppresses TNF-Stimulated NF-B
Transactivation
Under physiological conditions, the hepatocytes were
resistant to TNF-induced cell death because of NF-B–
mediated transcriptional regulation of anti-apoptotic pro-
teins. We, therefore, investigated whether 4-HNE affected
TNF-induced NF-B transactivity. As shown in Figure 3,
Figure 1. Long-term alcohol exposure increases hepatic TNF and 4-HNE
levels. A: Hepatic triglyceride (TG) contents. B: H&E staining. C: Plasma
alanine aminotransferase (ALT) levels. D: The TUNEL assay. E: Hepatic TNF
levels. F:Western blot analysis of long-term alcohol consumption on hepatic
4-HNE–protein adduct formation. Male C57BL/6 mice were pair fed liquid
diets, with or without ethanol, for 5 weeks. Data are expressed as the mean
SD (n 5 to 8 mice per group). *P 0.01 versus PF. AF, alcohol feeding; PF,
pair feeding.exposure to 4-HNE for 4 hours increased intracellular
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HepG2 cells and primary mouse hepatocytes (Figure
3A). Moreover, 4-HNE pretreatment dose dependently
suppressed TNF-induced increases in NF-B (p65) DNA-
binding activity in HepG2 cells (Figure 3, B and C). The
suppressive effect of 4-HNE on NF-B transactivity was
further corroborated by significantly decreased NF-B–
mediated gene expression after TNF stimulation (Figure
3D). To determine the in vivo relevance of 4-HNE–induced
suppression of NF-B activation in ALD, the nuclear frac-
tion was isolated from liver tissues and the DNA-binding
activity of NF-B (p65) was measured. As shown in Fig-
ure 3E, alcohol feeding decreased hepatic nuclear p65
DNA-binding activity.
4-HNE Inhibits IB Phosphorylation
After binding to its cell membrane receptor, TNF acti-
vated NF-B in the following order: i) IB phosphoryla-
tion by IKK, ii) ubiquitination and degradation of IB by
Figure 2. 4-HNE sensitizes hepatocytes to TNF cytotoxicity. A: 4-HNE sen-
sitizes HepG2 cells to TNF-induced cell death. HepG2 cells are pretreated
with exogenous 4-HNE for 2 hours before TNF stimulation. Cell death is
measured 16 hours later by MTT assay. Bars with different symbols (*, †, ‡, §,
¶) differ significantly from each other, all with a value of P  0.05. B and C:
4-HNE–induced sensitization to TNF hepatotoxicity in HepG2 cells is further
confirmed by an increased cleaved form of poly (ADP-ribose) polymerase
(PARP)-1 and fluorescence microscopic examination of Hoechst 33342 stain-
ing. HepG2 cells are pretreated with 20 mol/L 4-HNE for 2 hours, followed
by TNF (40 ng/mL) stimulation. D: 4-HNE exposure sensitizes both Hep3B
cells and primary mouse hepatocytes to TNF cytotoxicity. Both Hep3B and
primary hepatocytes are pretreated with 20 mol/L 4-HNE for 2 hours,
followed by TNF (40 ng/mL) stimulation. LDH releases are measured 16
hours later. All values are denoted as the mean  SD from three or more
independent studies. *P  0.05, **P  0.01 versus untreated (UT).26S proteasome, and iii) nuclear translocation. The phos-phorylation of IB was an obligatory step for these sub-
sequent events. To determine the mechanisms involved
in the suppressive effect of 4-HNE on NF-B activation,
we first examined the time course of 4-HNE on TNF-
induced phosphorylation of IB. As shown in Figure 4A,
TNF stimulation quickly increased IB phosphorylation
(15 minutes after TNF exposure), and the increase was
maintained during the 1-hour experimental period. Pre-
treatment with 4-HNE almost completely abolished TNF-
induced elevation of IB phosphorylation in both HepG2
and primary mouse hepatocytes, which was associated
with decreased nuclear p65 content (Figure 4B). More-
over, TNF stimulation induced rapid and transient IB
degradation (15 and 30 minutes after TNF). However, at
1 hour after TNF exposure, IB protein levels were
higher than control, suggestive of increased expression
of proteins targeted by NF-B, including IB protein
itself. This notion was further supported by the time-
matched IB decrease and NF-B suppression in
Figure 3. 4-HNE suppresses TNF-stimulated NF-B transactivation. A:
Exogenous 4-HNE exposure increases intracellular 4-HNE levels in both
HepG2 cells and primary hepatocytes. HepG2 cells are incubated with ex-
ogenous 4-HNE at the indicated doses for 8 hours. Whole cell lysates are
collected and used for the detection of intracellular 4-HNE contents by using
Western blot analysis. All values are expressed as the mean  SD from three
or more independent studies. *P  0.05, **P  0.01, and ***P  0.001 versus
untreated (UT). B and C: 4-HNE pretreatment suppresses TNF-induced in-
creases in NF-B (p65) DNA-binding activities in HepG2 cells. HepG2 cells
are pretreated with 4-HNE for 2 hours before TNF stimulation. Four hours
later, nuclear fractions are isolated and subjected to ELISA for the measure-
ment of p65 DNA-binding activities. Bars with different symbols (*, †, ‡, §, ¶,
ll) differ significantly from each other, all with a value of P  0.05. D: 4-HNE
pretreatment suppresses NF-B–mediated gene expression after TNF stimu-
lation. HepG2 cells are pretreated with 40 mol/L 4-HNE for 2 hours and
then incubated with 40 ng/mL TNF for 16 hours, total RNA is isolated, and
NF-B–regulated gene expression is determined by real-time RT-PCR. All
values are denoted as the mean  SD from three or more independent
studies. *P  0.05 versus UT. E: Alcohol feeding decreases hepatic nuclear
p65 DNA-binding activity. Data are expressed as the mean  SD (n  5 to 8
mice per group). *P  0.05 versus PF. AF, alcohol feeding; PF, pair feeding.
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lectively indicated that 4-HNE suppressed NF-B
transactivity via inhibition of IB phosphorylation. Be-
cause IKK was the dominant upstream kinase to
phosphorylate IB on TNF stimulation in hepatocytes,
we next determined whether decreased IB phos-
phorylation was due to altered IKK phosphorylation.
Western blot analysis using an antibody for phosphor-
ylated IKK/ protein showed that 4-HNE pretreatment
had no effects on IKK phosphorylation at 15 minutes
after TNF simulation (Figure 4C). The conclusion was
further confirmed by an ELISA specific for phosphory-
lated IKK (see Supplemental Figure S1 at http://ajp.
amjpathol.org). To determine whether exposure to exog-
enous 4-HNE led to increased 4-HNE–IB adduct for-
mation, immunoprecipitation analysis was conducted
to evaluate the modification of IB by 4-HNE. As
shown in Figure 4D, the 4-HNE–modified IB complex
was significantly increased by 4-HNE in both HepG2
Figure 4. 4-HNE exposure abolishes IB phosphorylation. A: 4-HNE pre-
treatment abolishes the TNF-stimulated increase in IB phosphorylation.
Both HepG2 cells and primary mouse hepatocytes are pretreated with 40
mol/L 4-HNE for 2 hours before TNF stimulation, and cell lysates are
collected at the indicated time points for Western blot analysis of phosphor-
ylated IB. B: 4-HNE pretreatment decreases nuclear p65 contents. HepG2
cells are pretreated with 4-HNE for 2 hours before TNF stimulation, and
nuclear fractions are collected 4 hours later and subjected to Western blot
analysis. C: 4-HNE pretreatment has no effects on the IKK phosphorylation.
HepG2 cells are pretreated with 40 mol/L 4-HNE for 2 hours before TNF
stimulation, and cell lysates are collected at 15 minutes after TNF exposure
for Western blot analysis of phosphorylated IKK.D: 4-HNE exposure results
in increased formation of the 4-HNE–IB complex. HepG2 cells are pre-
treated with 40 M 4-HNE for 2 hours before TNF stimulation, and cell lysates
are collected 1 hour later and subjected to immunoprecipitation and Western
blot analysis. E: Long-term alcohol exposure increases hepatic 4-HNE–IB
adduct contents, decreases hepatic nuclear p65 contents, and suppresses
hepatic IB phosphorylation. AF, alcohol feeding; H/T, 4-HNETNF; IB,
immunoblotting; IP, immunoprecipitation; PF, pair feeding; UT, untreated.cells and primary mouse hepatocytes compared withuntreated cells. To determine whether our observations
from cell culture were relevant to ALD, we measured
4-HNE–IB adduct formation, nuclear NF-B (p65)
contents, and IB phosphorylation status using either
nuclear or cytosolic proteins from pair- and alcohol-fed
mice. As shown in Figure 4E, long-term alcohol expo-
sure increased hepatic 4-HNE–IB adduct content,
suppressed hepatic IB phosphorylation, and de-
creased hepatic nuclear p65 contents.
Both Caspase Activation and Sustained JNK
Activation Contribute to 4-HNE/TNF-Induced
Cell Death
Both caspase activation and prolonged JNK activation
contributed to TNF-induced cell death under the condi-
tions of inhibited NF-B activation. To determine the
pathways involved in 4-HNE/TNF-induced cytotoxicity,
HepG2 cells were pretreated with 10 mol/L Z-VAD-FMK,
a pan-caspase inhibitor, or SP600125, a specific JNK
inhibitor, for 2 hours before exposure to 4-HNE/TNF. As
shown in Figure 5, A and B, both inhibitors alleviated cell
death in HepG2 cells, indicating that both caspase and
JNK activation were critically involved in 4-HNE/TNF-in-
duced hepatocyte cell death. A further examination re-
vealed that, although TNF stimulation led to rapid and
transient JNK activation, reaching peak levels at 0.5
hours and returning to basal levels at 2 hours, 4-HNE (40
mol/L) pretreatment caused a sustained TNF-mediated
JNK activation (Figure 5C).
Bezafibrate, a PPAR Agonist, Protects
Hepatocytes against 4-HNE/TNF-Induced Cell
Death
Many previous studies suggested that the deleterious
effects of 4-HNE may result from induction of oxidative
stress by decreased intracellular GSH levels. To deter-
mine whether 4-HNE–induced sensitization to TNF cyto-
toxity was mediated by inhibition of intracellular GSH, we
measured GSH levels in HepG2 cells exposed to 4-HNE.
As shown in Figure 6A, 4-HNE unexpectedly increased
intracellular GSH levels in HepG2 cells. Furthermore, pre-
treatment with NAC, an antioxidant serving as a GSH
precursor, did not confer protection against 4-HNE/TNF-
induced cell death (Figure 6B), confirming that oxidative
stress was not involved in 4-HNE–induced sensitization to
TNF cytotoxicity.
Long-term alcohol exposure was associated with de-
creased hepatic peroxisome proliferator-activated recep-
tor- (PPAR) activity, and PPAR agonists conferred a
beneficial effect in ALD. To determine whether the ben-
eficial effects of PPAR agonists may result from the
ability of these compounds to metabolize 4-HNE, bezafi-
brate was used. As shown in Figure 6C, 4-HNE/TNF-
induced cell death was significantly suppressed by beza-
fibrate (100 mol/L), which was associated with alleviated
p65–DNA-binding suppression by 4-HNE (Figure 6D). To
determine whether bezafibrate affected intracellular 4-HNE
metabolism, we next measured intracellular 4-HNE levels
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brate significantly reduced the intracellular 4-HNE accumu-
lation after 4-HNE exposure.
Preventive Effect of NAC on ALD Is Associated
with Decreased Hepatic 4-HNE Formation and
Improved NF-B Activity
The NAC protected from alcohol-induced liver injury.23
To determine whether prevention of hepatic 4-HNE for-
mation and improvement of NF-B activation were in-
volved in this protective process, an NAC-supple-
mented alcohol-containing diet was used. Five weeks
later, we measured hepatic 4-HNE content, 4-HNE–
IB adduct formation, and IB phosphorylation sta-
tus. Our results showed that, compared with alcohol-
Figure 5. Both caspase and sustained JNK activation contribute to 4-HNE/
TNF-induced cell death. A: Pan-caspase inhibitor almost completely prevents
4-HNE/TNF-induced LDH release from HepG2 cells. HepG2 cells are pre-
treated with 10 mol/L Z-VAD-FMK, a pan-caspase inhibitor, for 2 hours
before 4-HNE/TNF addition. LDH release is measured 16 hours later. All
values are expressed as the mean  SD from at least three experiments. Bars
with different letters differ significantly (P  0.05). B: Inhibition of JNK
activation alleviates cell death in HepG2 cells treated with 4-HNE and TNF.
HepG2 cells are pretreated with 10 mol/L SP600125, a specific JNK inhib-
itor, for 1 hour before 4-HNE/TNF addition. LDH release is measured 16
hours later. All values are expressed as the mean  SD from at least three
experiments. Bars with different symbols (*, †, ‡, §, ¶) differ significantly from
each other, all with a value of P  0.05. C: 4-HNE pretreatment causes a
sustained TNF-mediated JNK activation. HepG2 cells are pretreated with 40
mol/L 4-HNE for 2 hours before TNF stimulation. Whole cell lysates were
collected at the indicated time points and subjected to Western blot analysis
for phosphorylated JNK.fed mice, NAC supplementation attenuated liver injury(Figure 7A), which was associated with lowered he-
patic 4-HNE content (Figure 7B), decreased 4-HNE–
IB adduct formation (Figure 7C), and improved IB
phosphorylation status (Figure 7D).
Discussion
The goal of this study was to determine whether 4-HNE
and TNF synergistically contribute to the pathogenesis of
ALD. By using a well-established mouse model of ALD,
we found that alcohol-induced liver injury was accompa-
nied by increased hepatic 4-HNE formation and TNF
production. By using cultured hepatocytes, we demon-
Figure 6. Bezafibrate protects hepatocytes against 4-HNE/TNF-induced cell
death. A: Exogenous 4-HNE exposure increases intracellular GSH levels in
HepG2 cells. HepG2 cells are treated with 4-HNE, and the intracellular GSH
concentrations are measured at the indicated time points. All values are
expressed as the mean  SD from at least three experiments. *P  0.05
versus untreated (UT). B: Pretreatment with NAC does not confer protection
against 4-HNE/TNF-induced cell death. HepG2 cells are pretreated with 0.5
mmol/L NAC for 1 hour before 4-HNE/TNF exposure. Cell death is measured
by MTT assay 16 hours later. All values are expressed as the mean SD from
at least three experiments. Bars with different letters differ significantly (P 
0.05). C: Bezafibrate significantly suppresses LDH release induced by 4-HNE/
TNF from HepG2 cells. HepG2 cells are pretreated with 100 mol/L bezafi-
brate for 1 hour before 4-HNE/TNF exposure. LDH release is measured 16
hours later. All values are expressed as the mean  SD from at least three
experiments. Bars with different symbols (*, †, ‡, §, ¶) differ significantly from
each other, all with a value of P  0.05. D: Bezafibrate alleviates 4-HNE–
induced suppression on TNF-mediated p65 DNA-binding activity. HepG2
cells are pretreated with 100 mol/L bezafibrate for 1 hour before 4-HNE/
TNF exposure. The nuclear fraction is isolated for 2 hours and subjected to
ELISA. All values are expressed as the mean  SD from at least three
experiments. Bars with different letters differ significantly (P  0.05). E:
Bezafibrate significantly reduces the intracellular 4-HNE accumulation after
exogenous 4-HNE exposure. HepG2 cells are pretreated with 100 mol/L
bezafibrate for 2 hours before 4-HNE addition. Cell lysates are collected 8
hours later for Western blot analysis. All values are expressed as the mean 
SD from at least three experiments.
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duced cytotoxicity. Mechanistic investigations revealed a
significant increase in 4-HNE–IB adduct formation in
both 4-HNE–treated hepatocytes and the livers from al-
cohol-fed mice, which were associated with suppressed
IB phosphorylation, leading to suppressed NF-B ac-
tivation. By preventing intracellular 4-HNE accumulation,
bezafibrate, a PPAR agonist, conferred a protective ef-
fect against 4-HNE/TNF-induced cytotoxicity in hepato-
cytes. Finally, we demonstrated that the beneficial effect
of NAC supplementation on ALD was associated with
decreased hepatic 4-HNE formation and improved
NF-B activation.
The liver is the major site for alcohol metabolism. Long-
term alcohol exposure is associated with increased oxi-
dative stress and subsequent lipid peroxidation in the
liver. The physiological concentration of 4-HNE in plasma
is reported from 0.3 to 0.7 mol/L.24,25 A striking increase
of 4-HNE levels was found in the plasma of patients with
ALD, ranging from 2.8-fold in the early stage of liver insult
to 8.4-fold in the cirrhotic stage.26 In the liver, local cel-
lular concentrations may reach as high as 100 mol/L
in response to oxidative stress.27,28 In the present in vitro
study, 20 to 60 mol/L exogenous 4-HNE was used to
mimic in vivo early-stage ALD levels. Although a direct
Figure 7. The preventive effect of NAC supplementation on ALD is associ-
ated with decreased hepatic 4-HNE formation and improved NF-B activity.
A: NAC supplementation attenuates plasma alanine aminotransferase (ALT)
elevation. Data are expressed as the mean  SD (n  5 mice per group).
*P  0.05 versus AF. AF, alcohol feeding. B: NAC supplementation lowers
hepatic 4-HNE contents. C: NAC supplementation decreases hepatic 4-HNE–
IB adduct formation. IB, immunoblotting; IP, immunoprecipitation. D:
NAC supplementation improves hepatic IB phosphorylation status.cytotoxic effect of 4-HNE has been extensively docu-mented in a variety of cell types, hepatocytes are rela-
tively resistant to 4-HNE, even at pathophysiological con-
centrations, likely because of the relatively high capacity
of the 4-HNE degradation system.29 Data from our in vitro
experiments show that 4-HNE at 20 to 40 mol/L resulted
in a zero to minimal degree of cell death in both human
hepatocyte cell lines (HepG2 and Hep3B) and primary
mouse hepatocytes, but markedly sensitized these cells
to TNF-induced killing, suggesting that 4-HNE–induced
sensitization to TNF cytotoxicity represents a clinically
relevant process that may account for liver injury in ALD.
Dysregulated TNF production is a pathological factor
for ALD. Alcohol causes increased gut permeability, fol-
lowed by increased exposure of Kupffer cells to lipopoly-
saccharide, leading to elevated TNF production. NF-B
represents a master switch between life and death of
hepatocytes in response to TNF stimulation. Mice defi-
cient in the p65 NF-B subunit or essential components
of the IKK complex die during midgestation as the result
of massive hepatocyte apoptosis induced by TNF.30
Moreover, hepatocytes with a mutant IB are sensitive
to TNF killing.31 Data obtained from the current study
suggest that suppression of TNF-induced NF-B activa-
tion by 4-HNE contributes to increased sensitivity of
hepatocytes to TNF killing. This conclusion was sup-
ported by a series of observations, including the follow-
ing: i) 4-HNE pretreatment inhibited phosphorylation of
IB, an obligatory step for NF-B activation; ii) 4-HNE
decreased nuclear p65 content; iii) 4-HNE decreased
p65 DNA-binding activity; iv) 4-HNE reduced gene ex-
pression of NF-B–targeted anti-apoptotic molecules, in-
cluding cellular FLICE-like inhibitory protein, inhibitor of
apoptosis proteins-1, and manganese superoxide dismu-
tase; and v) inhibitors for either caspases or JNK activa-
tion attenuated 4-HNE/TNF-induced cell death. Although
the effects of 4-HNE on NF-B activation have been re-
ported, previous results were inconsistent and obviously
cell type and stimulus dependent. In vascular smooth
muscle cells, 4-HNE activated NF-B,32 whereas in hu-
man acute monocytic leukemia cell line monocytes,
4-HNE suppressed NF-B activation via inhibiting IB
phosphorylation stimulated by lipopolysaccharide, IL-1,
and phorbol-12-myristate-13-acetate, but not by TNF.33
To our knowledge, the current study is the first to report
that 4-HNE suppresses TNF-stimulated NF-B activation
in hepatocytes.
Unchanged IKK phosphorylation indicates that 4-HNE
could directly act on IB to prevent its phosphorylation
by IKK. One of the major mechanisms for 4-HNE to affect
protein function is through formation of 4-HNE–protein
adducts, a process called protein carbonylation. Indeed,
in our study, increased 4-HNE–IB adduct formation
was detected via immunoprecipitation. The exact mech-
anism underlying how 4-HNE–IB adduct formation pre-
vents its phosphorylation process remains to be fully
elucidated. In general, 4-HNE forms stable adducts with
proteins via reacting with amino acids, such as cysteine,
lysine, or histidine. Therefore, it is unlikely that 4-HNE
competes with IKK, which phosphorylates serine, for its
phosphorylation sites. One possibility is that 4-HNE may
alter IB protein conformation via protein adduct forma-
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phosphorylated by IKK.
Although the effects of long-term alcohol exposure on
hepatic NF-B activity have been reported, the results
were inconsistent and controversial. The discrepancy
could derive from differences in model selection, alcohol
concentration, feeding duration, and cell types studied.
In the present study, we clearly demonstrate that long-
term alcohol exposure decreases hepatic NF-B trans-
activity. These observations are consistent with several
previous studies.34–36 It is conceivable that long-term
alcohol exposure may differentially regulate NF-B activ-
ity in hepatocytes (inhibition) and Kupffer cells (activation
by lipopolysaccharide). In fact, this notion is supported
by a recent study demonstrating that long-term alcohol
consumption activated NF-B in Kupffer cells, whereas
NF-B activation in hepatocytes was inhibited.37
In conclusion, our study demonstrates that long-term
alcohol consumption results in a concomitant increase in
hepatic 4-HNE and TNF content, and that elevation of
intracellular 4-HNE sensitizes hepatocytes to TNF killing.
4-HNE–mediated suppression of NF-B activation is
mechanistically involved in 4-HNE/TNF-induced hepato-
cyte cell death. Our data provide important new informa-
tion concerning potential interactions between lipid per-
oxides and TNF- induced hepatotoxicity and its critical
involvement in the pathogenesis of ALD. Moreover, the
study also provides indirect evidence explaining the well-
established protective role of saturated fat (resistant to
peroxidation) in ALD. The inability of NAC protecting
against 4-HNE/TNF-induced hepatocyte cell death, along
with its preventive effects in animal models of ALD, may
partially explain the clinical controversies in terms of pre-
ventive versus therapeutic effects of antioxidants for ALD.
Together with many other hepatoprotective effects,
PPAR activation, via reducing intracellular 4-HNE accu-
mulation, as shown in this study, deserves further inves-
tigation as a potential therapy for ALD.
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